Skip to main content

Table 1 Characteristics of HD individuals concerning outcome of HCV infection

From: Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case–control study

Parameter

Spontaneous HCV clearance n = 83

Persistent HCV RNA positivity n = 104

P valuea

Male gender

43 (51.8)

57 (54.8)

0.768

Age at RRT onset, years

53.3 (7.2–85.9)

47.3 (8.7 –79.5)

0.011

Diabetic nephropathy

19 (22.9)

17 (16.3)

0.270

Chronic glomerulonephritis

16 (19.3)

37 (35.6)

0.015

Hypertensive nephropathy

9 (10.8)

11 (10.6)

1.000

RRT duration, years

7.12 (0.19–34.01)

13.32 (0.65–32.81)

0.002

BMI, kg/m2

24.43 (16.23–37.93)

23.18 (15.22–44.8)

0.165

HBsAg positivity

7 (8.4)

5 (4.8)

0.375

ALT, IU/L

12.9 (3–63)

22 (2–195)

0.0001

AST, IU/L

15 (8–50)

22 (7–152)

0.00005

ALP, IU/L

86.63 (45–803.75)

110 (34.5–647.25)

0.024

GGT, IU/L

19.7 (7–692)

39 (4–498)

0.001

C-reactive protein, mg/L

5.4 (0.3–105.5)

5.4 (0–90.7)

0.536

Albumin, g/dL

3.9 (2–36)

3.8 (1.9–38)

0.513

Platelet count, × 109/L

177 (93–397)

177 (70–405)

0.353

Total cholesterol (mg/dL)

156 (98.9–280)

158 (65–259)

0.394

HDL cholesterol (mg/dL)

38 (16.5–88)

40 (13–102)

0.318

LDL cholesterol (mg/dL)

82.5 (32–186.3)

84 (17.4–174)

0.700

TG (mg/dL)

139 (36.3–479)

139 (32–419)

0.577

Non-HDL-cholesterol (mg/dL)

120.25 (52–241)

117 (22.5–225)

0.306

LDL/HDL cholesterol ratio

0.641 (0.101–1.81)

0.632 (0.084–2.875)

0.987

HDL/TC ratio

0.236 (0.111–0.505)

0.272 (0.094–0.685)

0.054

TG/HDL cholesterol ratio

3.38 (0.65–25.55)

3.29 (0.74–27.93)

0.471

TG/HDL-cholesterol ratio ≥ 3.8

29 (41.4%)

38 (40.9%)

1.000

IFNL4 rs368234815 TT/TT

46 (55.4%)

33 of 102 (32.4%)

0.002

  1. Results are presented as median and range (minimum–maximum) or the number of individuals presenting the indicated parameter with the % of the total of tested individuals shown in parentheses
  2. aMann–Whitney test for quantitative variables, Fisher’s exact test for dichotomous variables
  3. Conversion factors to SI units are as follows: for alanine aminotransferase—1 IU/L = 0.0167 µkat/L, for albumin—1 g/dL = 10 g/L, for alkaline phosphatase—1 IU/L = 0.0167 µkat/L, for aspartate aminotransferase—1 IU/L = 0.0167 µkat/L, for cholesterols—1 mg/dL = 0.0259 mmol/L, for C-reactive protein—1 mg/L = 9.524 nmol/L, for gamma-glutamyltransferase—1 IU/L = 0.0167 µkat/L, for triglycerides—1 mg/dL = 0.0113 mmol/L
  4. ALP alkaline phosphatase, ALT alanine aminotransferase, AST aspartate aminotransferase, Anti-HCV antibodies against hepatitis C virus, BMI body mass index, GGT gamma-glutamyltransferase, HBsAg surface antigen of hepatitis B virus, HCV hepatitis C virus, HD hemodialysis, RRT renal replacement therapy